Filter
635
Filtered Results: 635
Text search:
Abdominal
Tuberculosis
Featured
Recommendations
107
New Publications
211
Language
Document type
No document type
390
Guidelines
138
Studies & Reports
59
Manuals
27
Training Material
13
Strategic & Response Plan
4
Brochures
1
Situation Updates
1
App
1
Infographics
1
Countries / Regions
India
82
South Africa
24
Kenya
18
Ethiopia
17
Nepal
15
Tanzania
15
Paraguay
15
Uganda
14
Argentina
13
Nigeria
12
Liberia
10
Rwanda
9
Malawi
9
Philippines
9
Global
9
Zambia
9
Western and Central Europe
8
Bangladesh
8
Ghana
7
Cambodia
7
Latin America and the Carribbean
7
Lesotho
6
Indonesia
6
Africa
5
Germany
5
Bolivia
5
Namibia
5
Myanmar / Burma
5
Eswatini/ Swaziland
5
Sierra Leone
4
Cameroon
4
Zimbabwe
4
South–East Asia Region
4
El Salvador
3
Benin
3
Senegal
3
Mozambique
3
North America
3
Botswana
3
Colombia
2
Syria
2
Peru
2
Venezuela
2
Jordan
2
Saudi Arabia
2
Sudan
2
Ecuador
2
Timor Leste/ East Timor
1
Gambia
1
Togo
1
Iran
1
Albania
1
Burkina Faso
1
Morocco
1
Asia
1
Dominican Republic
1
Congo, Democratic Republic of
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Uruguay
1
Tunisia
1
East and Southern Africa
1
Lebanon
1
Eastern Europe
1
Papua New Guinea
1
Nicaragua
1
Brazil
1
Greece
1
Georgia
1
Central African Republic
1
Honduras
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
348
Clinical Guidelines
119
Women & Child Health
55
Public Health
24
Key Resources
18
Capacity Building
14
Pharmacy & Technologies
1
Toolboxes
TB
100
HIV
42
NTDs
24
Caregiver
20
Pharmacy
20
Rapid Response
19
AMR
19
COVID-19
17
NCDs
11
Refugee
9
Ebola & Marburg
7
Conflict
6
Mental Health
4
Specific Hazards
1
Cholera
1
Planetary Health
1
Health Financing Toolbox
1
Global Health Education
1
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
Campaña Nacional de Vacunación contra la COVID-19
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Advising principles. The purpose of this document is to support competent authorities in charge of IHR implementation to improve national capacities for the prevention, detection and control of events, by strengthening communications and coordination between points of entry and the national health s...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
